The d-LIVER project is funded by the European Union’s 7th Framework Programme in response to FP7 ICT Call Objective ICT-2011.5.1: Personal Health Systems. It addresses the need for an ICT‑enabled bio-artificial liver support system (BAL) to facilitate detoxification as remote transient therapy at the point of need, offering continuous care from hospital to home settings.
Video demonstrating the motivation and the need for the d-LIVER project (Oct 2013)
The overall goal of the project is to provide safe and cost-effective systems for continuous, context-aware, multi-parametric monitoring of both patient and BAL system parameters in order to: enhance the quality of medical treatment and management; improve the quality of life for patients; reduce the incidence and duration of hospitalization and consequently reduce the health economic burden of chronic liver disease. d-LIVER will facilitate improved treatment whilst enabling patients to spend more time at home under constant, albeit remote, medical supervision.
This website is intended to give an overview of the project, its intentions, benefits and potential outcomes. This site addresses all relevant stakeholders, such as researchers, clinicians, health industry, funding bodies, regulatory organisations, healthcare providers, user groups and patients. Most of the website is in English language only, however, as we have clinicians and patients mainly involved from the UK and Germany, a page with patient information is also provided in German.
Anyone interested in the research carried out by the d-LIVER project should feel free to contact us, ask questions, make recommendations and request to be put on our mailing list for event invitations and news publications. Please e-mail us (with your own contact information) at: info(at)d-liver.eu.
We appreciate collaboration with other projects, clinics and healthcare industry! Also, we are happy to cross-link our website with other relevant and non-commercial websites. Additionally, we can accommodate your news and event announcements in our event and news sections.